|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Immune Thrombocytopenic Purpura | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Purpura | |||||
| Purpura, Thrombocytopenic | |||||
| Purpura, Thrombocytopenic, Idiopathic | |||||
| 3 | More general conditions related to this trial | ||||
| Autoimmune Diseases | |||||
| Blood Coagulation Disorders | |||||
| Blood Platelet Disorders | |||||
| Hematologic Diseases | |||||
| Hemorrhagic Disorders | |||||
| Immune System Diseases | |||||
| Signs and Symptoms | |||||
| Skin Manifestations | |||||
| Thrombocytopenia | |||||
| 4 | Sponsors listed in this trial | ||||
| National Heart, Lung, and Blood Institute (NHLBI) | |||||